Clarivate Plc (NYSE:CLVT) Director Blucher Sheryl G. Von sold 500,000 shares of the stock in a transaction dated Monday, June 14th. The stock was sold at an average price of $26.00, for a total value of $13,000,000.00. Following the sale, the director now directly owns 2,795,021 shares in the company, valued at approximately $72,670,546. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Shares of CLVT stock opened at $25.40 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.37. Clarivate Plc has a fifty-two week low of $20.82 and a fifty-two week high of $34.79. The company has a market capitalization of $15.54 billion, a P/E ratio of -195.38 and a beta of 0.54. The company has a 50 day moving average of $27.84.
Clarivate (NYSE:CLVT) last announced its earnings results on Sunday, May 9th. The company reported $0.14 earnings per share for the quarter, beating analysts’ consensus estimates of $0.13 by $0.01. Clarivate had a negative net margin of 3.90% and a positive return on equity of 5.49%. The firm had revenue of $428.43 million for the quarter, compared to analyst estimates of $417.66 million. On average, equities analysts forecast that Clarivate Plc will post 0.73 EPS for the current year.
Several equities research analysts have recently weighed in on the company. Zacks Investment Research cut Clarivate from a “buy” rating to a “hold” rating in a research report on Tuesday, March 2nd. B. Riley increased their target price on shares of Clarivate from $30.00 to $33.00 and gave the stock a “buy” rating in a research note on Friday, April 30th. Morgan Stanley raised their price target on shares of Clarivate from $30.00 to $32.00 and gave the company an “overweight” rating in a report on Tuesday, May 18th. Citigroup started coverage on Clarivate in a report on Thursday, March 11th. They set a “buy” rating and a $36.00 price objective for the company. Finally, Jefferies Financial Group began coverage on shares of Clarivate in a research report on Wednesday, March 31st. They set a “buy” rating and a $30.00 target price for the company. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $31.40.
Clarivate Company Profile
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs.
Featured Story: Stop Order
